SV

Street Verdict

Analyst Scorecard

A record of what Sumeet Bagadia said publicly, with the source. Not advice.

“Bullish on Eris Lifesciences, recommending a buy at ₹1340.7 with a target of ₹1420 and a stop loss at ₹1290 for intraday trading, citing strong technical charts and a recent breakout.”

Sumeet Bagadia’s track record (trackable calls only): 1528 graded calls · 95% CI 32–37%

Eris Lifesciences LtdBullishCalled 20 Mar 2025Graded 07 Apr 2025
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

Entry: ₹1,340.7, as stated.

Target ₹1,420, stop ₹1,290, as stated.

Window: 30 days, the time frame the call states ("intraday").

The stop ₹1,290 was reached on a close before the target ₹1,420. Miss.

The grader’s working: R3 TRADE_SETUP: entered ₹1314.65 on 2025-03-26 (stated entry ₹1340.7, DIP_LIMIT entry, filled); stop ₹1290 breached at close ₹1274.65 on 2025-04-07. Window 30 days — rule H1: the quote says "intraday" (a one-day claim, judged over 30 days; MISS if neither level is reached).

Tracking Eris Lifesciences Ltd since this call

1-year tracking window
Read the original articleSee Sumeet Bagadia’s full track record